Tafasitamab at the blood-brain barrier

被引：2

作者：

Rauschecker, Andreas M. ^{[1
]}

Mo, Shirley S. ^{[2
]}

Randall, Michael ^{[2
,3
]}

Shen-Sampas, John ^{[4
]}

Rubenstein, James L. ^{[2
,3
,5
,6
]}

机构：

[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA USA

[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA

[3] Univ Calif San Francisco, Hematol Oncol, San Francisco, CA USA

[4] Univ Calif San Francisco, Sch Med, San Francisco, CA USA

[5] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[6] Univ Calif San Francisco, Div Hematol Oncol, M1282 Box 1270, San Francisco, CA 94143 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷 / 01期

关键词：

blood-brain barrier; CD19; CNS lymphoma; immunotherapy; PRIMARY CNS LYMPHOMA; INTENSIVE CHEMOTHERAPY; CD19; IMMUNOTHERAPY; BLINATUMOMAB; ANTIBODY;

D O I：

10.1111/bjh.18660

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：154 / 157

页数：4

共 15 条

[1] Pericytes regulate the blood-brain barrier [J].

Armulik, Annika ;

Genove, Guillem ;

Mae, Maarja ;

Nisancioglu, Maya H. ;

Wallgard, Elisabet ;

Niaudet, Colin ;

He, Liqun ;

Norlin, Jenny ;

Lindblom, Per ;

Strittmatter, Karin ;

Johansson, Bengt R. ;

Betsholtz, Christer .

NATURE, 2010, 468 (7323) :557-U231

[2] Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study [J].

Goebeler, Maria-Elisabeth ;

Knop, Stefan ;

Viardot, Andreas ;

Kufer, Peter ;

Topp, Max S. ;

Einsele, Hermann ;

Noppeney, Richard ;

Hess, Georg ;

Kallert, Stefan ;

Mackensen, Andreas ;

Rupertus, Kathrin ;

Kanz, Lothar ;

Libicher, Martin ;

Nagorsen, Dirk ;

Zugmaier, Gerhard ;

Klinger, Matthias ;

Wolf, Andreas ;

Dorsch, Brigitte ;

Quednau, Beate D. ;

Schmidt, Margit ;

Scheele, Juergen ;

Baeuerle, Patrick A. ;

Leo, Eugen ;

Bargou, Ralf C. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) :1104-+

[3] Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells [J].

Gust, Juliane ;

Hay, Kevin A. ;

Hanafi, Laila-Aicha ;

Li, Daniel ;

Myerson, David ;

Gonzalez-Cuyar, Luis F. ;

Yeung, Cecilia ;

Liles, W. Conrad ;

Wurfel, Mark ;

Lopez, Jose A. ;

Chen, Junmei ;

Chung, Dominic ;

Harju-Baker, Susanna ;

Tzpolat, Tahsin ;

Fink, Kathleen R. ;

Riddell, Stanley R. ;

Maloney, David G. ;

Turtle, Cameron J. .

CANCER DISCOVERY, 2017, 7 (12) :1404-1419

[4] Low-dose lenalidomide maintenance after induction therapy in older patients with primary central nervous system lymphoma [J].

Khoan Vu ;

Mannis, Gabriel ;

Hwang, Jimmy ;

Geng, Huimin ;

Rubenstein, James L. .

BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (01) :180-183

[5] The prevention of central nervous system relapse in diffuse large B-cell lymphoma: a British Society for Haematology good practice paper [J].

McKay, Pamela ;

Wilson, Matthew R. ;

Chaganti, Sridhar ;

Smith, Jeffery ;

Fox, Christopher P. ;

Cwynarski, Kate .

BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (05) :708-714

[6] Blinatumomab: A historical perspective [J].

Nagorsen, Dirk ;

Kufer, Peter ;

Baeuerle, Patrick A. ;

Bargou, Ralf .

PHARMACOLOGY & THERAPEUTICS, 2012, 136 (03) :334-342

[7] Managing the toxicities of CAR T-cell therapy [J].

Neelapu, Sattva S. .

HEMATOLOGICAL ONCOLOGY, 2019, 37 :48-52

[8] Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions [J].

Orellana-Noia, Victor Manuel ;

Reed, Daniel R. ;

McCook, Ashley Alesia ;

Sen, Jeremy Michael ;

Barlow, Christian M. ;

Malecek, Mary-Kate ;

Watkins, Marcus ;

Kahl, Brad S. ;

Spinner, Michael A. ;

Advani, Ranjana ;

Voorhees, Timothy J. ;

Snow, Anson ;

Grover, Natalie Sophia ;

Ayers, Amy ;

Romancik, Jason ;

Liu, Yuxin ;

Huntington, Scott F. ;

Chavez, Julio C. ;

Saeed, Hayder ;

Lazaryan, Aleksandr ;

Raghunathan, Vikram ;

Spurgeon, Stephen E. ;

Ollila, Thomas A. ;

Del Prete, Christopher ;

Olszewski, Adam ;

Ayers, Emily C. ;

Landsburg, Daniel J. ;

Echalier, Benjamin ;

Lee, Jun ;

Kamdar, Manali ;

Caimi, Paolo F. ;

Fu, Timothy ;

Liu, Jieqi ;

David, Kevin A. ;

Alharthy, Hanan ;

Law, Jennie ;

Karmali, Reem ;

Shah, Harsh ;

Stephens, Deborah M. ;

Major, Ajay ;

Rojek, Alexandra E. ;

Smith, Sonali M. ;

Yellala, Amulya ;

Kallam, Avyakta ;

Nakhoda, Shazi ;

Khan, Nadia ;

Sohail, Mohammad Ahsan ;

Hill, Brian T. ;

Barrett-Campbell, Odeth ;

Lansigan, Frederick .

BLOOD, 2022, 139 (03) :413-423

[9] Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies [J].

Parker, Kevin R. ;

Migliorini, Denis ;

Perkey, Eric ;

Yost, Kathryn E. ;

Bhaduri, Aparna ;

Bagga, Puneet ;

Haris, Mohammad ;

Wilson, Neil E. ;

Liu, Fang ;

Gabunia, Khatuna ;

Scholler, John ;

Montine, Thomas J. ;

Bhoj, Vijay G. ;

Reddy, Ravinder ;

Mohan, Suyash ;

Maillard, Ivan ;

Kriegstein, Arnold R. ;

June, Carl H. ;

Chang, Howard Y. ;

Posey, Avery D., Jr. ;

Satpathy, Ansuman T. .

CELL, 2020, 183 (01) :126-+

[10] Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202) [J].

Rubenstein, James L. ;

Hsi, Eric D. ;

Johnson, Jeffrey L. ;

Jung, Sin-Ho ;

Nakashima, Megan O. ;

Grant, Barbara ;

Cheson, Bruce D. ;

Kaplan, Lawrence D. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) :3061-+

← 1 2 →